Annals ofAutoimmunity

Volume: 3 - Number: 24 - June 15, 2004

Seguimos creciendo para Brindar el mejor servicio

Systemic Lupus Erythematosus

Influence of everyday stressors on biochemical dynamics in systemic lupus erythematosus

Altered lipid raft–associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions

Therapeutic CD154 antibody for lupus: promise for the future?

Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus

CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice

Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides

Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes

Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease

Science in Medicine: Multiple sclerosis

Experimental arthritis in CC chemokine receptor 2–null mice closely mimics severe human rheumatoid arthritis

Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection

TNF- is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses

Impaired Smad7-Smurf–mediated negative regulation of TGF-ß signaling in scleroderma fibroblasts

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

Estrogen Metabolites: Increasing Evidence for Their Role in Rheumatoid Arthritis and Systemic Lupus Erythematosus

Subclinical Atherosclerosis in SLE

The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus

Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus

Acute lethal pancreatitis in childhood systemic lupus erythematosus

Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study

Immune responses to native ß2-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndrome

Family studies in systemic lupus erythematosus

Risk factors for developing systemic lupus erythematosus: a case–control study in southern Sweden

Neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: a case report

The contribution of HLA-DQB1 coding and QBP promoter alleles to anti-Ro alone autoantibody response in systemic lupus erythematosus

Psychological distress and changes in the activity of systemic lupus erythematosus

IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus

An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study

Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols

Decreased levels of soluble amyloid ?-protein precursor and ?-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus

Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis

Noticias del día

Buscador

Copyright © Dr. Mario I. Cámera .:. Powered by ForamenAlojado en ...